Alluvi Healthcare 40mg

In stock
Β£239.00 Β£230.00

Alluvi Healthcare's Retatrutide 40mg is a weight loss injection designed to support safe and effective weight management.

 

How it Works:*

 

 

 

- *Triple Agonist Action*: Targets three key hormones that influence appetite and metabolism (GLP-1, GIP, and glucagon).

 

- *Clinical Trials*: Has shown remarkable results in helping users shed weight quickly, with some participants losing up to 22% of their body weight in just nine months. 

 

*Product Details:

 

 

 

- *Dosage: 40mg Retatrutide formulation supplied in a pre-filled research device.

 

- *Storage: Store refrigerated (2-8°C) and do not freeze.

 

- *Delivery: Dispatched with a cold pack and tracked 1-day UK delivery.

 

 

 

*Potential Side Effects:

 

 

 

- *Common Side Effects: Nausea, diarrhea, and constipation.

 

- *Serious Side Effects: May include pancreatitis, gallstones, loss of muscle mass, and weakened in bones.

 

- *Kidney Issues: Some trials reported kidney stones and potential kidney problems.

 

 

 

*Important Considerations:

 

 

 

- *Regulatory Status: Retatrutide is still under research, and its approval status varies by country.

 

- *Counterfeit Products: Be cautious of counterfeit versions, especially those sold online without proper regulation